LYCOS RETRIEVER
England: Companies
built 622 days ago
BIRMINGHAM, England, February 19 PRNewswire — Business intelligence now sits at the top of most IT budgets, yet most deployments are still far from complete. This is costing companies thousands of pounds everyday, and some are considering abandoning projects altogether.
Source:
Former executives of Bristol-Myers Squibb established Pharmapac in 1996, when BMS closed its plant in Wirral, England. Today, Pharmapac has become a low-cost, high-quality provider of contract production and packaging services to a blue-chip list of pharmaceutical companies. Pharmapac's areas of expertise -- solids (tablets and capsules), semi-solids (gels), creams, liquids, sachet filling, powders and wound-care solutions -- augment and expand Inyx's capabilities to ensure that an optimum level of packaging technology and expertise can be offered to clients. Pharmapac's 42,000-square foot facilities in Wirral are about an hour drive from Inyx's current two U.K. sites ... located in the North West of England. Inyx said it would retain all of Pharmapac's 200-plus present employees, including executives who will further strengthen Inyx's existing operating and technical management teams.
Source:
CLEVELAND, Sept. 18 /PRNewswire-FirstCall/ -- The Lubrizol Corporation (NYSE: LZ) announced today that it has entered into an agreement with D1 Oils plc (D1), a UK-based global producer of biodiesel, to sell its 47-acre Bromborough, England manufacturing site. The sale price is 3.0 million pounds sterling (approximately $5.7 million US). D1 plans to convert the site to biodiesel production during 2007. On January 17, 2005, Lubrizol announced its plans to phase out production of additives for fuels, additives for engine oil lubricants, and specialty monomers at the Bromborough site by year end 2006. At that time, the company estimated that restructuring costs, including employee severance and other plant closure costs (including planned demolition costs), would be approximately $15.0 million. The company now estimates that the sale of the site will save approximately $3.0-$5.0 million in restructuring costs that would have been associated with demolition of the plant facilities on the site.
Source: